UroFusion-X: a unified multimodal deep learning framework for robust diagnosis, subtyping, and prognosis of urological cancers - Takeaways - MDSpire

UroFusion-X: a unified multimodal deep learning framework for robust diagnosis, subtyping, and prognosis of urological cancers

  • By

  • Yingming Xiao

  • Shengke Yang

  • Mingjing He

  • Li Chen

  • Yi Wu

  • Lei Zhong

  • January 19, 2026

  • 0 min

Share

  • 1

    UroFusion-X is a unified framework designed for the diagnosis, subtyping, and prognosis of urological cancers using multimodal data integration.

  • 2

    The framework employs modality-specific encoders and a cross-modal co-attention fusion module to enhance diagnostic accuracy and robustness.

  • 3

    UroFusion-X demonstrates superior performance compared to unimodal and simple fusion methods, retaining over 90% accuracy under missing modality scenarios.

  • 4

    The framework incorporates an anatomy-pathology consistency constraint to improve interpretability and cross-modal alignment in clinical settings.

  • 5

    UroFusion-X shows potential for real-world deployment, improving decision consistency and reducing unnecessary testing in urological cancer management.

Original Source(s)

UroFusion-X: a unified multimodal deep learning framework for robust diagnosis, subtyping, and prognosis of urological cancers

  • by Yingming Xiao, Shengke Yang, Mingjing He, Li Chen, Yi Wu, Lei Zhong

  • January 19, 2026

Related Content

Diagnostic accuracy of abbreviated biparametric MRI for prostate cancer screening: a prospective feasibility study (ReIMAGINE study)

Serial T1 and T2 measurements of metastatic bone lesions in prostate cancer patients: MR fingerprinting vs conventional MRI

The role of microflow patterns combined with greyscale ultrasound in enhancing diagnostic validity and reducing unnecessary biopsy rate of thyroid nodules